Aktuelle Aspekte in der Therapie des Vorhofflimmerns – „Highlights“ der DGK-Jahrestagung 2015
Standard
Aktuelle Aspekte in der Therapie des Vorhofflimmerns – „Highlights“ der DGK-Jahrestagung 2015. / Meyer, Christian; Jungen, Christiane; Willems, Stephan.
in: Kardiologie up2date, Jahrgang 11, Nr. 3, 2015, S. 139-142.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Aktuelle Aspekte in der Therapie des Vorhofflimmerns – „Highlights“ der DGK-Jahrestagung 2015
AU - Meyer, Christian
AU - Jungen, Christiane
AU - Willems, Stephan
N1 - Konferenzbericht, nicht score
PY - 2015
Y1 - 2015
N2 - Atrial fibrillation (AF) is the most common arrhythmia prompting clinical presentation. Of the available pharmacologic and non-pharmacologic treatment options, the fastest growing and most intensely studied is catheter-based ablation therapy for AF. Pulmonary vein isolation is the cornerstone of catheter ablation of paroxysmal AF. Meanwhile, the optimal ablation strategy beyond PVI in peristent AF remains to be elucidated. Several ablation approaches targeting the morphological or/and the functional substrate of AF are currently under investigation. Planning and evaluation of these novel ablation strategies needs to be strictly controlled in clinical studies. The latter might be improved by using miniaturized, implantable event recorders for continuous heart rhythm monitoring
AB - Atrial fibrillation (AF) is the most common arrhythmia prompting clinical presentation. Of the available pharmacologic and non-pharmacologic treatment options, the fastest growing and most intensely studied is catheter-based ablation therapy for AF. Pulmonary vein isolation is the cornerstone of catheter ablation of paroxysmal AF. Meanwhile, the optimal ablation strategy beyond PVI in peristent AF remains to be elucidated. Several ablation approaches targeting the morphological or/and the functional substrate of AF are currently under investigation. Planning and evaluation of these novel ablation strategies needs to be strictly controlled in clinical studies. The latter might be improved by using miniaturized, implantable event recorders for continuous heart rhythm monitoring
U2 - 10.1055/s-0034-1393072
DO - 10.1055/s-0034-1393072
M3 - Andere (Vorworte u.ä.)
VL - 11
SP - 139
EP - 142
JO - Kardiologie up2date
JF - Kardiologie up2date
SN - 1611-6534
IS - 3
ER -
